The recent papers in th e J efferson J ournal of Psychia t r y b y Drs. Le vin ("Bulimia as a Masturbatory Equivalent, " Jul y, 198 5) a nd Wil son ("A Discussion of ' Bu lim ia as a Ma sturbatory Equi valent' ," Winter, 1986) co ntai n a num be r of th eories and recommendations abo u t th e e tio logy a nd treatm en t of b ulimi a whi ch shou ld be ad d resse d. In large measure , both papers pr ese nt a d yn ami c vie w of this disorder. H o we ver, psych odynami c fo r m u la t io ns are bu t one of man y theories put forward to e xp lain this di sorder. Other t heories of etiolo gy in clude notions that bulimia a r ises from cu ltu ra l fac tors and an in creased a tten tio n to body image , from di so rde rs with in th e fa mi ly as a whole , or from ass o rted behavioral fac to rs wh ich so me how r einforce binge-ea ti ng a nd pu rgm g.
One wa y to e valuat e a theory o f e tio logy is to as k wh ethe r t reatme n ts ba sed upon a giv en theory benefit individuals with th e disorde r in questio n . Fo r e xa m p le , it would be of interest to know what e vidence e xists that individ ua l psychoth erapy is superior to group psychotherapy for th e treatm en t of b ul im ia . Similarly it is important to know what e m p ir ica l data underlie th ese theories. In th e case o f bulimia, as noted above , th ere are a h ost o f id eas a bout wha t causes the di sorde r. And whil e a review of this literature is be yond th e scope of this paper, at this time th ere is no systematic, controlle d, non-an ecd ot al evidence that psych odynamic, beha vioral , o r cu ltura l factors a lo ne ca n lead to b ul im ia (1,2) .
In terms of treatment, we h av e a sim ila r situa t io n, wh ere co ntro lled st udies of individual psychoth erapy, group th erapy, and behavior th erapy a re a lso lacking. There are numerous un controlled r eports of th e efficacy of th ese modal ities in bulimic pati ents, but it is important to note wh y co ntro lled studies are important in assessing treatm ents of this dis order. First , bulimia may remit sp o n ta ne o us ly ( I), so that a placebo group is needed to evalua te if a giv en th erapy is e ffect ive . Second, bulimic pati ents ma y hav e a mel iora tio n of sym ptom s in str uc tu red se tt ings. In assessing th e fir st 40 consecuti ve inpatients admitted to the Fair Oaks Hospital Eating Disorders program , 33 h ad complete cessation of binging within the first 10 da ys. Such a response is misl eading . At the end of two weeks (before treatment is completed) nearly tw o-th irds of the 33 "responders" will binge and purge on their first pass, and nearly all of the 33 "responders" will report urges to binge during the first two weeks. T his kind of phenomenon points out the need for a control group, as wel l as follow-up information, before a given treatment can be sa id to be effecti ve.
Given the prevalence of bulimia, there are relativel y few stu dies of psychological and group treatments. One difficulty often cited in d esign in g studies is that response to therapy cannot be assessed in a systematic ma nner. I n bulimia, this is not the case. Bulimic patients have a number of ov ert sym p to ms which can be followed readily, such as the number of binge and purge e p isodes each day , severity of binge and purge urges, and se ve r ity of depression . T h us , t here seems little reason why studies of therapeutic efficacy of various modalities could not be undertaken . Yet data supporting the use of many p opular th erapi es a re scanty at best. There are at this time no co n tro lled studies of individual psych othe ra py in bulimia beyond uncontrolled cas e se r ies . Cognitive beha vio ral th era py has been reported successful in two uncontrolled studies (3 ,4) , wh ereas th e rapy has been reported useful in several uncontrolled reports (5-9).
We are not advocating that individuals with bulimia be d eprived of group or individual therapy. Rather, we are pointing out that at th is time th e re is litt le to commend one talking therapy from another. Recommendations for group and individual therapy should be made on an individual basis, rather than on the basis of diagnosis alone. In conjunction with such treatment, howe ve r , we must now address the use of a different therapeutic technique which appears applicable to this diagnostic category as a whole-the use of a n tidep ressa nt med ication.
The rationale for the use of antidepressants in bulimia co mes from th e bod y of evidence linking bulimia and anorexia nervosa to affecti ve di sorders. T his evidence stems from three lines of research: studies of phenomenol ogy, family history, and biological tests. Studies of phenomenology have examined groups of bulimic patients seeking treatment for their eating disorde r. Su ch studies have consistently reported that bulimic patients have an in creased life ti me prevalence of major depression and bipolar disorder, and that in up to 50 percent of cases the affective disorder antedates the onset of th e ea ting di sor de r (10) (11) (12) . Studies of family history also suggest a biological link between affect ive disorders and bulimia, in that most but not all groups have reported an in creased incidence of affective disorders in the families of patients with bulimia (13) (14) (15) .
The third line of evidence linking eating disorders to affecti ve di sor d e rs arises from studies of the dexamethasone suppression test (DS T) a nd th yrotr opin releasing hormone stimulation test (TRHST). Both the DST (14 ,16 ,17) and TRHST (14) yield positive results in bulimia at rates co m parab le to those observed among individuals with depression. These r esults sho u ld be inte rpreted with caution, since metabolic stresses a ttr ib u tab le to binging, p urging , admitted to the Fair O a ks Hospital Eating Disorders program , 33 had complet e cessation of binging within the first 10 days. Such a response is mislead ing. At the end of two weeks (before treatment is completed) nearl y two-thi rds of th e 33 " r espo nd ers " will b inge and purge on their fir st pa ss, and nearly a ll of the 33 "responders" will report urges to binge during the first two week s. T h is kind of phenomenon points out the need for a control group, as we ll as follow-up information , before a given treatment can be said to be effec tive.
Gi ven the prevalence of bulimia, there are relativel y fe w studies o f psych olog ical and group treatments. One difficulty often cit ed in d esigning studies is that re sponse to therapy cannot be assessed in a syste mat ic m ann er. In bu limi a , this is not the case. Bul im ic patients have a number of o vert sym ptoms wh ich can be followed readi ly, such as the number of binge and purge e pisodes ea ch day, severity of binge and purge urges, and severity of depression. Thus, th ere seems little reason why studies of therapeutic efficacy of various modalities co uld not be u nd e r tak en . Yet d ata supporting t he use of many popular th e rapies are scanty at best. There are at this time no controlled studies of individual psych otherap y in bulimia beyond uncontrolled case series. Cognitive behavi oral th erapy has been reported successful in two uncontrolled studies (3, 4) , wh ereas th erap y ha s been reported useful in several uncontrolled reports (5-9).
We are not advocating that individuals with bulimia be d epri ved of group o r individual therapy. Rather, we are pointing out that at this time th ere is little to co m me nd one talking th erapy from another. Recommendations fo r group and individual therapy should be made on an indi vidual ba sis, rathe r th an o n th e ba sis of diagnosis alone. In conjunction with such treatment, how e ve r , we must now address the use of a different th erapeutic technique whic h a ppears a pp licable to this diagnostic catego r y as a whole-the use of antidepressa nt medication .
The rationale for the use of antidepressants in bulimia co mes from th e body of evidence linking bulimia and anorexia nervosa to affec t ive di sorders. This evidence stems from three lines of research : stud ies of ph en omenology, fam ily history , and biological tests. Studies of phenomenology have exam ined group s of b ulim ic patients seeking treatment for their eating di sorder. Su ch st udies have consistently reported that bu limic patients have an in creased life time prevalence of maj o r depression and b ipolar disorder, and that in up to 50 percent of cases th e affective disorder an tedates the onset of th e eating di sorder (10) (11) (12) . Studies offam ily h istor y a lso suggest a biological link between affect ive di sorders and bulimi a , in that most bu t not all groups have reported an increased inci dence of affective disorders in the families of patients with bulimia (13) (14) (15) .
The third line of evidence lin king eating di sorders to affec tive d iso rd ers arises from studies of the dexamethasone suppression test (DST) and th yr o tropin releasing hormone stimulation test (T RHST). Both th e DST ( 14 , 16, 17) and TRHST ( 14) yiel d positive results in bulimia at rates co mpara b le to those observed among individuals with depression . These results shou ld be int erpreted with caution, since metabolic str esses attr ib u ta ble to bing ing , purg ing, and weight loss could produce false positive results (18) . H o wever, st udies of inpatient bulimics have shown that the rate of dexamethasone non-su pp r esio n is not affected by hospitalization , even after binging and purging are co ntrolled through milieu treatment (16, 19) .
The evidence summarized above suggests a biologica l link betwee n bulimia and the affective disorders. It should be noted that th ere a re aspects of th e eat ing disorders not explained b y this linkage, suc h as th e rel at ionsh ip of eating disorders and substance abuse (20) . However, th e affecti ve model of eating disorders has led to an important treatment o f bulimia , th e use of antidepressant medication.
Numerous open-studies of antidepressants in bulimia hav e a ppeared in the literature since 1977 (1,2) , describing the use of heterocyclic a n tidepressants and monoamine oxidase inhibitors (MAOI's). Since th en , five pla cebocontrolled, double-blind studies of heterocyclic antidepressants or MAOI's have been completed (21) (22) (23) (24) (25) . One study using low dosages of mianserin had negative resu lts (21) , and one study using amitriptyline had weakly positive results (22) . Both studies appeared to suffer from the use of inadequate dosages of antidepressant. The other three studies of antidepressants reported strongly positive findings. Pope et al. (23) observed a 70 percent reduction o f b in ge-eat in g in patients taking imipramine in dosages up to 200 mg each d ay, as co mpared to vir t ua lly no change in a placebo-control group. Significant reductions in depressio n , food preoccupation , and subjective global improvement we re also noted . Walsh et al. had similarly positive re sults using phenelzin e (23), as d id Hugh es et al. using desipramine (24) . The study by Hughes and co lleagues was of particu lar interest because ·they selected bulimic patients who did no t d isplay major d epression. Despite this fact , Hughes' group found that 15 (68 %) of 22 subjects experienced a remission of th eir bulimic sym p to ms within ten wee ks. Another important finding of the Hughes study was that pla sma le vels of d esip ram ine comparable to those required in depression were required fo r res po nse, and that dosages up to 350 mg of desipramine were required to obtain adeq ua te serum levels (125-275 ug /ml in their laboratory).
Overall, a growing body of evidence supports th e use of a nt idep ressant medication in the treatment of bulimia, whether or not th e patient suffers from co nco m itant major depression. Follow-up data from th e study o f Pope e t al. further support the utility of antidepressants (26) . After o ne to two yea rs o n medication, 50 percent of patients were free of bulimic symptoms, 4 5 percent had a greater than 50 percent reduction of symptoms, and only one pa tien t, who had discontinued medication , was unchanged. These promisin g data are tempered by the fact that complicated pharmacologic treatments were requi red in so me ca ses in order to achieve maximal results. Nevertheless, a majority of these patients were able to return to full function , and did so without th e aid of other ancillary therapies.
A number of caveats should be rai sed at this point. First, age nts o ther than antidepressants have been useful in bulimia , including lithium (27) , and meth ylamphetamine (28) . Naltrexone has a lso been reported to be of use in these patients (29) , but only on an o pen-label basis. In ge neral, treatment with th ymoleptics must be syste m atic and care fu l utilizing medication in adequate dosages for adequate pe ri ods of time , ca refu lly monitorin g seru m levels (30) . Second, medication does not interfere with psych otherapy. If anything the co gn itive improvement whi ch patients exper ie nce wh en d epressio n and food preoccupation lessen make th em more amenable to th erapy.
Third, the notion th at patients sho uld be allowed to " e xper ie nce " thei r eat ing di sorder in order to achieve insight should be co ns idered as archa ic and cr uel as notions that antidepressants sho uld be withheld from d epressed individual s for like reasons. Such an approach is also medicall y d an ge rous, in light o f the ph ysical damage whi ch may attend constant binging and purging . The role of treatment is to hasten recovery, and antidepressant th erapy ca n hel p in this regard.
Finally, clinicians often misinterpret the use of a nt idep ressa nts as a de facto state me n t against the use of ps ychotherapy. This is untrue. Many if not most patients with bulimia will have individual and famil y problem s whic h require indi vidual , group, and family psychotherapy. In our o wn treatmen t p rogram , patients are e ngaged in all of th ese th erapies, in addition to mi lie u, n u tritional, and exe rc ise therapy. In treating the whole patient, one needs to address biological as well as psychological needs. In so d oing , t he use of thymoleptics pl ays an important role. Given th e evidence fo r th e efficacy of antidepressants in bulimia , th ere is little rea son to withhold th em from pat ie nt s with t his disorder. 
